Kundu SD - Search Results

1

Absence of proximal duct apoptosis in the ventral prostate of transgenic mice carrying the C3(1)-TGF-beta type II dominant negative receptor.

Kundu SD, Kim IY, Yang T, Doglio L, Lang S, Zhang X, Buttyan R, Kim SJ, Chang J, Cai X, Wang Z, Lee C. Kundu SD, et al. Prostate. 2000 May 1;43(2):118-24. doi: 10.1002/(sici)1097-0045(20000501)43:2<118::aid-pros6>3.0.co;2-v. Prostate. 2000. PMID: 10754527

2

Absence of expression of transforming growth factor-beta type II receptor is associated with an aggressive growth pattern in a murine renal carcinoma cell line, Renca.

Kundu SD, Kim IY, Zelner D, Janulis L, Goodwin S, Engel JD, Lee C. Kundu SD, et al. J Urol. 1998 Nov;160(5):1883-8. J Urol. 1998. PMID: 9783979

3

Transforming growth factor-beta in benign and malignant prostate.

Lee C, Sintich SM, Mathews EP, Shah AH, Kundu SD, Perry KT, Cho JS, Ilio KY, Cronauer MV, Janulis L, Sensibar JA. Lee C, et al. Among authors: kundu sd. Prostate. 1999 Jun 1;39(4):285-90. doi: 10.1002/(sici)1097-0045(19990601)39:4<285::aid-pros9>3.0.co;2-7. Prostate. 1999. PMID: 10344218 Review.

4

Transforming growth factor-beta type II receptor confers tumor suppressor activity in murine renal carcinoma (Renca) cells.

Engel JD, Kundu SD, Yang T, Lang S, Goodwin S, Janulis L, Cho JS, Chang J, Kim SJ, Lee C. Engel JD, et al. Among authors: kundu sd. Urology. 1999 Jul;54(1):164-70. doi: 10.1016/s0090-4295(99)00093-x. Urology. 1999. PMID: 10414746

5

Down-regulation of TGF-beta1 production restores immunogenicity in prostate cancer cells.

Matthews E, Yang T, Janulis L, Goodwin S, Kundu SD, Karpus WJ, Lee C. Matthews E, et al. Among authors: kundu sd. Br J Cancer. 2000 Aug;83(4):519-25. doi: 10.1054/bjoc.2000.1257. Br J Cancer. 2000. PMID: 10945501 Free PMC article.

6

Suppression of tumor metastasis by blockade of transforming growth factor beta signaling in bone marrow cells through a retroviral-mediated gene therapy in mice.

Shah AH, Tabayoyong WB, Kundu SD, Kim SJ, Van Parijs L, Liu VC, Kwon E, Greenberg NM, Lee C. Shah AH, et al. Among authors: kundu sd. Cancer Res. 2002 Dec 15;62(24):7135-8. Cancer Res. 2002. PMID: 12499244

7

Infiltration of tumor-reactive transforming growth factor-beta insensitive CD8+ T cells into the tumor parenchyma is associated with apoptosis and rejection of tumor cells.

Zhang Q, Jang TL, Yang X, Park I, Meyer RE, Kundu S, Pins M, Javonovic B, Kuzel T, Kim SJ, Van Parijs L, Smith N, Wong L, Greenberg NM, Guo Y, Lee C. Zhang Q, et al. Prostate. 2006 Feb 15;66(3):235-47. doi: 10.1002/pros.20340. Prostate. 2006. PMID: 16173028

8

The leader sequence triggers and enhances several functions of clusterin and is instrumental in the progression of human prostate cancer in vivo and in vitro.

Zhang Q, Zhou W, Kundu S, Jang TL, Yang X, Pins M, Smith N, Jovanovic B, Xin D, Liang L, Guo Y, Lee C. Zhang Q, et al. BJU Int. 2006 Aug;98(2):452-60. doi: 10.1111/j.1464-410X.2006.06263.x. BJU Int. 2006. PMID: 16879694

9

Blockade of transforming growth factor-{beta} signaling in tumor-reactive CD8(+) T cells activates the antitumor immune response cycle.

Zhang Q, Yang XJ, Kundu SD, Pins M, Javonovic B, Meyer R, Kim SJ, Greenberg NM, Kuzel T, Meagher R, Guo Y, Lee C. Zhang Q, et al. Among authors: kundu sd. Mol Cancer Ther. 2006 Jul;5(7):1733-43. doi: 10.1158/1535-7163.MCT-06-0109. Mol Cancer Ther. 2006. PMID: 16891459

10

The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells.

Kundu SD, Lee C, Billips BK, Habermacher GM, Zhang Q, Liu V, Wong LY, Klumpp DJ, Thumbikat P. Kundu SD, et al. Prostate. 2008 Feb 1;68(2):223-9. doi: 10.1002/pros.20710. Prostate. 2008. PMID: 18092352

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters